5 completed. 3 Phase 4, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression Selegiline Transdermal System, Placebo - Major Depressive Disorder | Phase 4 | Completed | Somerset Pharmaceuticals | 308 | 2007-07-01 | 2014-01-15 |
| PK Comparison of 6mg and 12mg EMSAM in Elderly vs. Non-Elderly EMSAM (Selegiline Transdermal System) 6mg, EMSAM (Selegiline Transdermal System) 12mg - Healthy | Phase 4 | Completed | Somerset Pharmaceuticals | 32 | 2007-04-01 | 2007-09-19 |
| Evaluation of Adhesion and Dermal Tolerability of EMSAM EMSAM (Selegiline Transdermal System) 6mg/24Hr, EMSAM (Selegiline Transdermal System) 9mg/24Hr, EMSAM (Selegiline Transdermal System) 12mg/24hr - Healthy | Phase 4 | Completed | Somerset Pharmaceuticals | 300 | 2007-04-01 | 2007-09-19 |
| Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression Selegiline Transdermal System - Major Depression | Phase 3 | Completed | Somerset Pharmaceuticals | 300 | 2002-08-01 | 2008-04-22 |
| Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 Selegiline - Cocaine-Related Disorders | Phase 3 | Completed | National Institute on Drug Abuse (NIDA) | 269 | 2001-03-01 | 2017-01-12 |
Depression (2) · Depressive Disorder, Major (2) · Cocaine-Related Disorders (1) · Psychological Well-Being (1)
Selegiline (4)
United States (5)
Ahmed Elkashef, MD (1) · Melissa Goodhead (1) · Melissa L Goodhead (1) · Thomas Hochadel, Pharm.D. (1)